Linden Thomas Advisory Services, LLC Neurocrine Biosciences Inc Transaction History
Linden Thomas Advisory Services, LLC
- $647 Billion
- Q2 2024
A detailed history of Linden Thomas Advisory Services, LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Linden Thomas Advisory Services, LLC holds 5,796 shares of NBIX stock, worth $845,520. This represents 0.12% of its overall portfolio holdings.
Number of Shares
5,796
Previous 6,768
14.36%
Holding current value
$845,520
Previous $933 Million
14.52%
% of portfolio
0.12%
Previous 0.15%
Shares
7 transactions
Others Institutions Holding NBIX
# of Institutions
634Shares Held
94.6MCall Options Held
472KPut Options Held
245K-
Black Rock Inc. New York, NY13.8MShares$2.01 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.93MShares$1.45 Billion0.03% of portfolio
-
State Street Corp Boston, MA3.99MShares$582 Million0.02% of portfolio
-
Jpmorgan Chase & CO New York, NY2.3MShares$335 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.25MShares$328 Million0.49% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $14B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...